On January 1, The New York Times published an article, “When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong,” followed by a discussion with the author on their popular podcast, The Daily, entitled, “An Investigation into Flawed...
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
Today, June 13th, 2018, marks the 5-year anniversary of the Supreme Court of the United States’ Association for Molecular Pathology v. Myriad Genetics case regarding the BRCA gene patent. The result was a unanimous decision: genes could not be patented as they...
